Clinical Trials Browser

Unknown × surufatinib × Head & Neck × Clear all

NCT04910854 2021-06-02

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Phase 2 Unknown

Head and Neck Cancers - Salivary Gland

NCT04524884 2020-08-24

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Phase 2 Unknown

Thyroid Neoplasms